Advertisement
|
|
news roundup
Updated employee announcements, business news, awards, and recognition in the industry today.
| Advertisement
A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden
Thursday, October 11, 2018 at 11am EDT
 Register Now |
Veeva Systems announced a next-generation cloud application to streamline clinical data management and accelerate study execution. With this new cloud application, companies will only need one application that will allow them to manage study build through execution and gain a complete and concurrent view of all clinical data within a trial.
| Advertisement
On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
Thursday, October 4, 2018 at 11am EDT
 Register Now |
Athens Medical Group (AMG) in Greece has joined Clinerion's hospitals network, which includes its Athens Medical Center and their Medsana Bucharest Medical Center in Romania.
| Advertisement
Research Reveals Data Quality Issues Slow Clinical Trial Progression – What Can You Do To Prevent This?
Wednesday, October 3, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
 Register Now |
PAREXEL's Patient Innovation Center is launched to help sponsors navigate patient centricity from protocol, through study implementation and commercialization access.
|
|
|
| Advertisement
Artificial Intelligence: A Transformative Journey for Pharmacovigilance
Thursday, September 27, 2018 at 11am EDT
 Register Now |
| Advertisement
Challenging the Status Quo: The Diffusion of Technology in Study Startup
Tuesday, September 25, 2018 at 1pm EDT | 12pm CDT | 10am PDT
 Register Now |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
The region is significantly underrepresented in clinical development activity targeting childhood cancer.
| Advertisement
A Next Generation Sequencing Approach to Influenza Vaccine Development
On Demand
 Learn more |
In this study, Clinical Trials Transformation Initiative's database for aggregate analysis of ClinicalTrials.gov was used to evaluate the number of ongoing and completed interventional clinical trials for various coronary diseases.
|
|
Blog Posts
Columnist Moe Alsumidae speaks to key Synteract executives on their acquisition of a dermatology CRO to augment its own expertise and grow the specific services necessary for this therapeutic specialty.
| Advertisement
Decoding the Distinction: DMCs, CECs, and Their Role in Medical Device Research
On Demand
 Learn more |
Market players working on development of vaccines to fight against the virus are focused on clinical trials and look forward to gaining approval from regulatory bodies.
|
|
RBM
Sponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.
|
|
|
CluePoints has launched the "CluePoints RBM and ICH E6 (R2) Starter Pack" to help small and medium-sized enterprises achieve regulatory compliance through a "risk-based" approach. This starter pack helps to address the problem of embracing RBM through the use of consultation on the ICH E6 addendum and RBM methodology. This will further help organizations understand the regulation and aims to improve costs and resources all while providing them with the necessary tools.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
